# Everolimus

NDC: 70377-070
Generic name: EVEROLIMUS
Labeler / Manufacturer: Biocon Pharma Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20250602

FDA application: ANDA216140

## Active ingredients

- EVEROLIMUS: .5 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"70377-070"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70377-070
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=435da284-ef0e-ca90-e0db-bab9382922e0